MeSH D001932 - brain neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Methylprednisolone | Methylprednisolone | 1982-01-01 | |||
| Prednisolone | Prednisolone | 1982-01-01 | ||||
| Abbott Biotherapeutics | Methylprednisolone | A-methapred | 1991-02-22 | |||
| AbbVie | Prednisolone | Pred | 1982-01-01 | |||
| Prednisolone | Pred Mild | 1982-01-01 | ||||
| Accord Healthcare | Carmustine | Carmustine | 2022-12-27 | |||
| Etoposide | Etoposide | 1996-03-14 | ||||
| Alcon Research | Prednisolone, Sulfacetamide | Cetapred | 1993-08-06 | |||
| Prednisolone, Sulfacetamide | Isopto Cetapred | 1982-01-01 | ||||
| Prednisolone | Prednisolone | 1991-10-24 | ||||
| Alembic Pharmaceuticals | Carmustine | Carmustine | 2023-10-20 | |||
| Allergan | Prednisolone, Sulfacetamide | Blephamide | 1986-12-03 | |||
| Prednisolone, Chloramphenicol | Chloroptic-p | 1982-01-01 | ||||
| Prednisolone, Neomycin, Polymyxin b | Poly-pred | 1982-01-01 | ||||
| Prednisolone, Gentamicin | Pred | 1988-06-10 | ||||
| Etoposide | Etoposide | 1996-10-15 | ||||
| Methylprednisolone | Methylprednisolone | 1997-10-16 | ||||
| Prednisolone | Prednisolone | 1982-01-01 | ||||
| Prednisolone tebutate | Prednisolone Tebutate | 1984-02-17 | ||||
| Amneal Pharmaceuticals | Carmustine | Carmustine | 2018-10-16 | |||
| Methylprednisolone | Methylprednisolone | 2021-09-21 | ||||
| Prednisolone | Prednisolone | 2009-03-10 | ||||
| APP Pharmaceuticals | Methylprednisolone | Methylprednisolone | 1984-06-08 | |||
| Aurobindo Pharma | Prednisolone | Prednisolone | 2023-03-17 |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
58%94/163
Phase 2
29%48/163
Phase 3
31%23/75
Approved: 14Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use